962 related articles for article (PubMed ID: 21813548)
21. Achievement of Remission and Low Disease Activity Definitions in Patients with Rheumatoid Arthritis in Clinical Practice: Results from the NOR-DMARD Study.
Uhlig T; Lie E; Norvang V; Lexberg ÅS; Rødevand E; Krøll F; Kalstad S; Olsen IC; Kvien TK
J Rheumatol; 2016 Apr; 43(4):716-23. PubMed ID: 26879358
[TBL] [Abstract][Full Text] [Related]
22. Performances of Clinical Disease Activity Index (CDAI) and Simplified Disease Activity Index (SDAI) appear to be better than the gold standard Disease Assessment Score (DAS-28-CRP) to assess rheumatoid arthritis patients.
Dhaon P; Das SK; Srivastava R; Dhakad U
Int J Rheum Dis; 2018 Nov; 21(11):1933-1939. PubMed ID: 28608433
[TBL] [Abstract][Full Text] [Related]
23. Activity indices in rheumatoid arthritis.
Villaverde V; Balsa A; Cantalejo M; Fernández-Prada M; Madero MR; Muñoz-Fernández S; Gijón-Baños J; Martín-Mola E
J Rheumatol; 2000 Nov; 27(11):2576-81. PubMed ID: 11093436
[TBL] [Abstract][Full Text] [Related]
24. In patients with early rheumatoid arthritis, the new ACR/EULAR definition of remission identifies patients with persistent absence of functional disability and suppression of ultrasonographic synovitis.
Sakellariou G; Scirè CA; Verstappen SM; Montecucco C; Caporali R
Ann Rheum Dis; 2013 Feb; 72(2):245-9. PubMed ID: 23060009
[TBL] [Abstract][Full Text] [Related]
25. Response criteria for rheumatoid arthritis in clinical practice: how useful are they?
Gülfe A; Geborek P; Saxne T
Ann Rheum Dis; 2005 Aug; 64(8):1186-9. PubMed ID: 15760931
[TBL] [Abstract][Full Text] [Related]
26. Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints.
Aletaha D; Smolen JS
Arthritis Rheum; 2011 Dec; 63(12):3702-11. PubMed ID: 21953215
[TBL] [Abstract][Full Text] [Related]
27. Simplified versions of the original disease activity score: validation in the BeSt trial.
Koevoets R; Klarenbeek NB; Güler-Yüksel M; van Oosterhout M; van Krugten MV; Kerstens PJ; Huizinga TW; Dijkmans BA; van der Heijde DM; Allaart CF
Ann Rheum Dis; 2011 Aug; 70(8):1471-4. PubMed ID: 21551508
[TBL] [Abstract][Full Text] [Related]
28. A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti-tumor necrosis factor alpha agents.
Lurati A; Pontikaki I; Teruzzi B; Desiati F; Gerloni V; Gattinara M; Cimaz R; Fantini F
Arthritis Rheum; 2006 May; 54(5):1602-7. PubMed ID: 16646003
[TBL] [Abstract][Full Text] [Related]
29. How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?
Fleischmann R; van der Heijde D; Koenig AS; Pedersen R; Szumski A; Marshall L; Bananis E
Ann Rheum Dis; 2015 Jun; 74(6):1132-7. PubMed ID: 25143522
[TBL] [Abstract][Full Text] [Related]
30. Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA.
Keystone E; Freundlich B; Schiff M; Li J; Hooper M
J Rheumatol; 2009 Mar; 36(3):522-31. PubMed ID: 19228659
[TBL] [Abstract][Full Text] [Related]
31. Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis.
Balsa A; Carmona L; González-Alvaro I; Belmonte MA; Tena X; Sanmartí R;
J Rheumatol; 2004 Jan; 31(1):40-6. PubMed ID: 14705217
[TBL] [Abstract][Full Text] [Related]
32. Remission by composite scores in rheumatoid arthritis: are ankles and feet important?
Kapral T; Dernoschnig F; Machold KP; Stamm T; Schoels M; Smolen JS; Aletaha D
Arthritis Res Ther; 2007; 9(4):R72. PubMed ID: 17662115
[TBL] [Abstract][Full Text] [Related]
33. Comparison of long-term clinical outcome with etanercept treatment and adalimumab treatment of rheumatoid arthritis with respect to immunogenicity.
Krieckaert CL; Jamnitski A; Nurmohamed MT; Kostense PJ; Boers M; Wolbink G
Arthritis Rheum; 2012 Dec; 64(12):3850-5. PubMed ID: 22933315
[TBL] [Abstract][Full Text] [Related]
34. Definition of treatment response in rheumatoid arthritis based on the simplified and the clinical disease activity index.
Aletaha D; Martinez-Avila J; Kvien TK; Smolen JS
Ann Rheum Dis; 2012 Jul; 71(7):1190-6. PubMed ID: 22454398
[TBL] [Abstract][Full Text] [Related]
35. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score.
Aletaha D; Nell VP; Stamm T; Uffmann M; Pflugbeil S; Machold K; Smolen JS
Arthritis Res Ther; 2005; 7(4):R796-806. PubMed ID: 15987481
[TBL] [Abstract][Full Text] [Related]
36. Comparative study of indices of activity evaluation in rheumatoid arthritis.
Hamdi W; Néji O; Ghannouchi MM; Kaffel D; Kchir MM
Ann Phys Rehabil Med; 2011 Oct; 54(7):421-8. PubMed ID: 21996547
[TBL] [Abstract][Full Text] [Related]
37. Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission.
Aletaha D; Wang X; Zhong S; Florentinus S; Monastiriakos K; Smolen JS
Semin Arthritis Rheum; 2020 Apr; 50(2):276-284. PubMed ID: 31590930
[TBL] [Abstract][Full Text] [Related]
38. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
[TBL] [Abstract][Full Text] [Related]
39. Does clinical remission lead to normalization of EQ-5D in patients with rheumatoid arthritis and is selection of remission criteria important?
Linde L; Sørensen J; Østergaard M; Hørslev-Petersen K; Hetland ML
J Rheumatol; 2010 Feb; 37(2):285-90. PubMed ID: 20080905
[TBL] [Abstract][Full Text] [Related]
40. Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study.
Burmester GR; Ferraccioli G; Flipo RM; Monteagudo-Sáez I; Unnebrink K; Kary S; Kupper H
Arthritis Rheum; 2008 Jan; 59(1):32-41. PubMed ID: 18163417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
